{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:56:23Z","timestamp":1790798183298,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003194","name":"Agent\u00fara Ministerstva \u0160kolstva, Vedy, V\u00fdskumu a \u0160portu SR","doi-asserted-by":"publisher","award":["VEGA 1\/0250\/25"],"award-info":[{"award-number":["VEGA 1\/0250\/25"]}],"id":[{"id":"10.13039\/501100003194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"DOI":"10.1007\/s40266-026-01338-1","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:18:30Z","timestamp":1790749110000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patterns of Evidence-Based Medication Use in Older Adults with Chronic Heart Failure in Slovakia: A Population-Based Study Using the National Health Information Center Database"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7672-1574","authenticated-orcid":false,"given":"Martin","family":"Wawruch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Mrazova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kisac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Mojzesova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gasparovicova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Murin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Vulevova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Matalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofa D.","family":"Alfian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Aarnio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"1338_CR1","doi-asserted-by":"publisher","unstructured":"Seferovic PM, Vardas P, Jankowska EA, et al. National heart failure societies of the ESC member countries (see Appendix). The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019. Eur J Heart Fail. 2021;23(6):906\u201314. https:\/\/doi.org\/10.1002\/ejhf.2143.","DOI":"10.1002\/ejhf.2143"},{"issue":"15","key":"1338_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12154924","volume":"12","author":"A Ruiz-Garc\u00eda","year":"2023","unstructured":"Ruiz-Garc\u00eda A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Mart\u00ednez E, Tur\u00e9gano-Yedro M, Pallar\u00e9s-Carratal\u00e1 V. Heart failure prevalence rates and its association with other cardiovascular diseases and chronic kidney disease: SIMETAP-HF study. J Clin Med. 2023;12(15):4924. https:\/\/doi.org\/10.3390\/jcm12154924.","journal-title":"J Clin Med"},{"key":"1338_CR3","doi-asserted-by":"publisher","unstructured":"Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129\u2013200. https:\/\/doi.org\/10.1093\/eurheartj\/ehw128.","DOI":"10.1093\/eurheartj\/ehw128"},{"issue":"7","key":"1338_CR4","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1002\/ejhf.2894","volume":"25","author":"SD Anker","year":"2023","unstructured":"Anker SD, Usman MS, Anker MS, et al. Patient phenotype profiling in heart failure with preserved ejection fraction to guide therapeutic decision making. A scientific statement of the Heart Failure Association, the European Heart Rhythm Association of the European Society of Cardiology, and the European Society of Hypertension. Eur J Heart Fail. 2023;25(7):936\u201355. https:\/\/doi.org\/10.1002\/ejhf.2894.","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"1338_CR5","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342\u201356. https:\/\/doi.org\/10.1002\/ejhf.1858.","journal-title":"Eur J Heart Fail"},{"key":"1338_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.678614","volume":"8","author":"P Li","year":"2021","unstructured":"Li P, Zhao H, Zhang J, et al. Similarities and differences between HFmrEF and HFpEF. Front Cardiovasc Med. 2021;8:678614. https:\/\/doi.org\/10.3389\/fcvm.2021.678614.","journal-title":"Front Cardiovasc Med."},{"issue":"6","key":"1338_CR7","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.3390\/jcm14061982","volume":"14","author":"M Montalto","year":"2025","unstructured":"Montalto M, D\u2019Ignazio F, Camilli S, et al. Heart failure in older patients: an update. J Clin Med. 2025;14(6):1982. https:\/\/doi.org\/10.3390\/jcm14061982.","journal-title":"J Clin Med"},{"issue":"3","key":"1338_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/ejhf.1741","volume":"22","author":"B Pieske","year":"2020","unstructured":"Pieske B, Tsch\u00f6pe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur J Heart Fail. 2020;22(3):391\u2013412. https:\/\/doi.org\/10.1002\/ejhf.1741.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"1338_CR9","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","volume":"34","author":"FP Brouwers","year":"2013","unstructured":"Brouwers FP, de Boer RA, van der Harst P, et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND. Eur Heart J. 2013;34(19):1424\u201331. https:\/\/doi.org\/10.1093\/eurheartj\/eht066.","journal-title":"Eur Heart J"},{"issue":"36","key":"1338_CR10","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599\u2013726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368.","journal-title":"Eur Heart J"},{"key":"1338_CR11","doi-asserted-by":"publisher","unstructured":"Zinman B, Wanner C, Lachin JM, et al. EMPA-REG OUTCOME Investigators. empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328. https:\/\/doi.org\/10.1056\/NEJMoa1504720","DOI":"10.1056\/NEJMoa1504720"},{"key":"1338_CR12","doi-asserted-by":"publisher","unstructured":"McDonagh TA, Metra M, Adamo M, et al. ESC Scientific Document Group. 2023 Focused update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627\u201339. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195","DOI":"10.1093\/eurheartj\/ehad195"},{"issue":"2","key":"1338_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40266-024-01165-2","volume":"42","author":"A Hashemi","year":"2025","unstructured":"Hashemi A, Kwak MJ, Goyal P. Pharmacologic management of heart failure with preserved ejection fraction (HFpEF) in older adults. Drugs Aging. 2025;42(2):95\u2013110. https:\/\/doi.org\/10.1007\/s40266-024-01165-2.","journal-title":"Drugs Aging"},{"issue":"6","key":"1338_CR14","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"TM Maddox","year":"2021","unstructured":"Maddox TM, Januzzi JL Jr, Allen LA, et al. 2021 update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the american college of cardiology solution set oversight committee. J Am Coll Cardiol. 2021;77(6):772\u2013810. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.022.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"1338_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s40266-025-01265-7","volume":"43","author":"E Maury","year":"2026","unstructured":"Maury E, Van der Linden L, Bogaerts K, Belmans A, Jansen M. Effectiveness of sacubitril\/valsartan in reducing hospitalizations in older Belgian adults with heart failure and reduced ejection fraction: an age-stratified study. Drugs Aging. 2026;43(1):89\u201398. https:\/\/doi.org\/10.1007\/s40266-025-01265-7.","journal-title":"Drugs Aging"},{"issue":"1","key":"1338_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s40266-024-01166-1","volume":"42","author":"A Visaria","year":"2025","unstructured":"Visaria A, McDonald W, Mancini J, et al. Changes in medication complexity and post-hospitalization outcomes in older adults hospitalized for heart failure. Drugs Aging. 2025;42(1):69\u201380. https:\/\/doi.org\/10.1007\/s40266-024-01166-1.","journal-title":"Drugs Aging"},{"issue":"4","key":"1338_CR17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","volume":"72","author":"SJ Greene","year":"2018","unstructured":"Greene SJ, Butler J, Albert NM, et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351\u201366. https:\/\/doi.org\/10.1016\/j.jacc.2018.04.070.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1338_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020501","volume":"9","author":"GC Oh","year":"2020","unstructured":"Oh GC, Cho HJ, Lee SE, et al. Management and prognosis of heart failure in octogenarians: final report from the KorAHF registry. J Clin Med. 2020;9(2):501. https:\/\/doi.org\/10.3390\/jcm9020501.","journal-title":"J Clin Med"},{"issue":"6","key":"1338_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/ejhf.2483","volume":"24","author":"D Stolfo","year":"2022","unstructured":"Stolfo D, Lund LH, Becher PM, et al. Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata. Eur J Heart Fail. 2022;24(6):1047\u201362. https:\/\/doi.org\/10.1002\/ejhf.2483.","journal-title":"Eur J Heart Fail"},{"key":"1338_CR20","unstructured":"ICD\u201310th International Statistical Classification of Diseases and Related Health Problems, 10th revision. WHO: Geneva, 1992; 191."},{"key":"1338_CR21","unstructured":"Guidelines for ATC classification and DDD assignment 2025. WHO Collaborating Centre for Drug Statistics Methodology: Oslo, 2025; 257."},{"key":"1338_CR22","first-page":"382","volume-title":"Biostatistical methods in epidemiology","author":"SC Newman","year":"2001","unstructured":"Newman SC. Biostatistical methods in epidemiology. Chichester: Wiley; 2001. p. 382."},{"key":"1338_CR23","doi-asserted-by":"publisher","unstructured":"Solomon SD, McMurray JJV, Anand IS, et al. PARAGON-HF investigators and committees. angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction. N Engl J Med. 2019;381(17):1609\u201320.https:\/\/doi.org\/10.1056\/NEJMoa1908655","DOI":"10.1056\/NEJMoa1908655"},{"issue":"8","key":"1338_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00228-016-2052-y","volume":"72","author":"R Zarrinkoub","year":"2016","unstructured":"Zarrinkoub R, Kahan T, Johansson SE, W\u00e4ndell P, Mejhert M, Wettermark B. How to best assess quality of drug treatment in patients with heart failure. Eur J Clin Pharmacol. 2016;72(8):965\u201375. https:\/\/doi.org\/10.1007\/s00228-016-2052-y.","journal-title":"Eur J Clin Pharmacol"},{"key":"1338_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2261-12-60","volume":"12","author":"JY Kim","year":"2012","unstructured":"Kim JY, Kim HJ, Jung SY, Kim KI, Song HJ, Lee JY, et al. Utilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims database. BMC Cardiovasc Disord. 2012;12:60. https:\/\/doi.org\/10.1186\/1471-2261-12-60.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"1338_CR26","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/ejhf.1199","volume":"20","author":"M Trevisan","year":"2018","unstructured":"Trevisan M, de Deco P, Xu H, et al. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists. Eur J Heart Fail. 2018;20(8):1217\u201326. https:\/\/doi.org\/10.1002\/ejhf.1199.","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"1338_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026187","volume":"11","author":"CH Garred","year":"2022","unstructured":"Garred CH, Zahir D, Butt JH, et al. Adherence and discontinuation of optimal heart failure therapies according to age: a Danish nationwide study. J Am Heart Assoc. 2022;11(19):e026187. https:\/\/doi.org\/10.1161\/JAHA.122.026187.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"1338_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1080\/02813432.2017.1397253","volume":"35","author":"M Giezeman","year":"2017","unstructured":"Giezeman M, Arne M, Theander K. Adherence to guidelines in patients with chronic heart failure in primary health care. Scand J Prim Health Care. 2017;35(4):336\u201343. https:\/\/doi.org\/10.1080\/02813432.2017.1397253.","journal-title":"Scand J Prim Health Care"},{"issue":"5","key":"1338_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1177\/08971900211004840","volume":"35","author":"KV Smith","year":"2022","unstructured":"Smith KV, Dunning JR, Fischer CM, et al. Evaluation of the usage and dosing of guideline-directed medical therapy for heart failure with reduced ejection fraction patients in clinical practice. J Pharm Pract. 2022;35(5):747\u201351. https:\/\/doi.org\/10.1177\/08971900211004840.","journal-title":"J Pharm Pract"},{"key":"1338_CR30","doi-asserted-by":"publisher","unstructured":"Komajda M, Anker SD, Cowie MR, et al. QUALIFY Investigators. Physicians' adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey. Eur J Heart Fail. 2016;18(5):514\u201322.https:\/\/doi.org\/10.1002\/ejhf.510","DOI":"10.1002\/ejhf.510"},{"issue":"9","key":"1338_CR31","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2409257","volume":"24","author":"G Wang","year":"2023","unstructured":"Wang G, Liu L, Wang X, et al. Analysis of physician compliance with guideline-directed medical therapy for patients with heart failure with reduced ejection fraction: a real-world study. Rev Cardiovasc Med. 2023;24(9):257. https:\/\/doi.org\/10.31083\/j.rcm2409257.","journal-title":"Rev Cardiovasc Med"},{"issue":"6","key":"1338_CR32","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1111\/jep.12760","volume":"23","author":"V Khalil","year":"2017","unstructured":"Khalil V, Danninger M, Wang W, Khalil H. An audit of adherence to heart failure guidelines in an Australian hospital: a pharmacist perspective. J Eval Clin Pract. 2017;23(6):1195\u2013202. https:\/\/doi.org\/10.1111\/jep.12760.","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"1338_CR33","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1002\/ehf2.15193","volume":"12","author":"NC Berry","year":"2025","unstructured":"Berry NC, Sheu YS, Chesbrough K, Bishop RC, Vupputuri S. Guideline-directed medical therapy rates in heart failure patients with reduced ejection fraction in a diverse cohort. ESC Heart Fail. 2025;12(3):1861\u201371. https:\/\/doi.org\/10.1002\/ehf2.15193.","journal-title":"ESC Heart Fail."},{"issue":"12","key":"1338_CR34","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.cjco.2022.08.003","volume":"4","author":"M Wahid","year":"2022","unstructured":"Wahid M, Aghanya V, Sepehrvand N, Dover DC, Kaul P, Ezekowitz J. Use of guideline-directed medical therapy in patients aged \u2265 65 years after the diagnosis of heart failure: a Canadian population-based study. CJC Open. 2022;4(12):1015\u201323. https:\/\/doi.org\/10.1016\/j.cjco.2022.08.003.","journal-title":"CJC Open"},{"issue":"38","key":"1338_CR35","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, et al. 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178.","journal-title":"Eur Heart J"},{"issue":"33","key":"1338_CR36","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, Mancia G, Spiering W, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104. https:\/\/doi.org\/10.1093\/eurheartj\/ehy339.","journal-title":"Eur Heart J"},{"key":"1338_CR37","doi-asserted-by":"publisher","unstructured":"Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa612.","DOI":"10.1093\/eurheartj\/ehaa612"},{"issue":"2","key":"1338_CR38","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","volume":"58","author":"C Espinola-Klein","year":"2011","unstructured":"Espinola-Klein C, Weisser G, Jagodzinski A, et al. \u03b2-Blockers in patients with intermittent claudication and arterial hypertension: results from the nebivolol or metoprolol in arterial occlusive disease trial. Hypertension. 2011;58(2):148\u201354. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.169169.","journal-title":"Hypertension"},{"issue":"9","key":"1338_CR39","doi-asserted-by":"publisher","first-page":"675","DOI":"10.2459\/01.JCM.0000285316.71057.26","volume":"8","author":"D Del Sindaco","year":"2007","unstructured":"Del Sindaco D, Pulignano G, Cioffi G, et al. Safety and efficacy of carvedilol in very elderly diabetic patients with heart failure. J Cardiovasc Med (Hagerstown). 2007;8(9):675\u201382. https:\/\/doi.org\/10.2459\/01.JCM.0000285316.71057.26.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"24","key":"1338_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413488","volume":"22","author":"L Cuenca-Bermejo","year":"2021","unstructured":"Cuenca-Bermejo L, Almela P, Navarro-Zaragoza J, et al. Cardiac changes in Parkinson\u2019s disease: lessons from clinical and experimental evidence. Int J Mol Sci. 2021;22(24):13488. https:\/\/doi.org\/10.3390\/ijms222413488.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"1338_CR41","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","volume":"17","author":"RF Pfeiffer","year":"2020","unstructured":"Pfeiffer RF. Autonomic dysfunction in Parkinson\u2019s disease. Neurotherapeutics. 2020;17(4):1464\u201379. https:\/\/doi.org\/10.1007\/s13311-020-00897-4.","journal-title":"Neurotherapeutics"},{"issue":"11","key":"1338_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-016-0739-5","volume":"18","author":"CM Celano","year":"2016","unstructured":"Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016;18(11):101. https:\/\/doi.org\/10.1007\/s11920-016-0739-5.","journal-title":"Curr Psychiatry Rep"},{"key":"1338_CR43","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/9619388","volume":"2023","author":"T Qiu","year":"2023","unstructured":"Qiu T, Jiang Z, Chen X, Dai Y, Zhao H. Comorbidity of anxiety and hypertension: common risk factors and potential mechanisms. Int J Hypertens. 2023;2023:9619388. https:\/\/doi.org\/10.1155\/2023\/9619388.","journal-title":"Int J Hypertens"},{"issue":"5","key":"1338_CR44","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.hlc.2024.03.008","volume":"33","author":"G Tini","year":"2024","unstructured":"Tini G, Tanda S, Toma M, et al. Guideline-directed medical therapy in patients with heart failure with reduced ejection fraction and incident cancer. Heart Lung Circ. 2024;33(5):704\u20139. https:\/\/doi.org\/10.1016\/j.hlc.2024.03.008.","journal-title":"Heart Lung Circ"},{"issue":"1","key":"1338_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1089\/pmr.2022.0014","volume":"3","author":"I Azar","year":"2022","unstructured":"Azar I, Wang S, Dhillon V, et al. Preferences and attitudes of cardiologists in management of patients with cancer. Palliat Med Rep. 2022;3(1):279\u201386. https:\/\/doi.org\/10.1089\/pmr.2022.0014.","journal-title":"Palliat Med Rep."},{"issue":"4","key":"1338_CR46","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/00045391-200607000-00005","volume":"13","author":"S Khosla","year":"2006","unstructured":"Khosla S, Ahmed A, Siddiqui M, et al. Safety of angiotensin-converting enzyme inhibitors in patients with bilateral renal artery stenosis following successful renal artery stent revascularization. Am J Ther. 2006;13(4):306\u20138. https:\/\/doi.org\/10.1097\/00045391-200607000-00005.","journal-title":"Am J Ther"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01338-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01338-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:03:01Z","timestamp":1790794981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01338-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":46,"alternative-id":["1338"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01338-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]},"assertion":[{"value":"1 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Martin Wawruch, Mariana Mrazova, Viktor Foltin, Peter Kisac, Zuzana Mojzesova, Simona Gasparovicova, Jan Murin, Tomas Tesar, Miriam Vulevova, Petra Matalova, Sofa D. Alfian and Emma Aarnio declare that they have no conflicts of interest relevant to this manuscript.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data that support the findings of this study were made available by the National Health Information Center; however, because of the restrictions on their availability, the data were used under a license issued for the purposes of the current study and are thus not publicly available. Nevertheless, the data may be obtained from the authors upon a reasonable request and with the permission of the National Health Information Center.","order":2,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"According to the legal principles of the Slovak Republic, our register-based study did not require the approval of an Ethical Committee. The patient data were anonymised under license from the National Health Information Center. The rules of personal data confidentiality were fully respected.","order":3,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"As this was an analysis of existing data, informed consent was not obtained.","order":4,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualisation: MW, MM, VF, SDA, EA. Data curation: MW, MM, VF, SG. Formal analysis: MW, MM, VF. Funding acquisition: MW, JM, TT. Project administration: MW, JM. Validation: MW, MM. All authors contributed to investigation, methodology, writing\u2013original draft and writing\u2013review and editing. All authors approved the final version of the manuscript.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}